Lyophilization of RNA
AssigneeCureVac Real Estate GmbH
InventorsThomas Ketterer, Thorsten Mutzke, Michael Wiggenhorn, Frank Schaubhut, Florian Von Der Mülbe
Life of this patent
Estimating the term…
Loading patent…
AssigneeCureVac Real Estate GmbH
InventorsThomas Ketterer, Thorsten Mutzke, Michael Wiggenhorn, Frank Schaubhut, Florian Von Der Mülbe
Estimating the term…
The present invention is directed to the field of RNA formulation, in particular to lyophilization of RNA. The invention provides a method for lyophilization of RNA. The present invention further concerns a lyophilized composition obtainable by the inventive method, a pharmaceutical composition, a vaccine and a kit or kit of parts. Moreover, the present invention provides a novel use of a lyoprotectant for lyophilizing RNA, the use of the inventive method in the manufacture of a medicament as well as the first and second medical use of the composition obtainable by the inventive method, the pharmaceutical composition, the vaccine or the kit or kit of parts according to the invention.
A method for lyophilizing a long-chain RNA composition, wherein the method comprises the following steps:
A method for lyophilizing a mRNA, wherein the method comprises the following steps:
A method for lyophilizing a mRNA composition, wherein the method comprises the following steps:
Dependencies are inferred from the claim text.